Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-03-29

FDA Approved: POTASSIUM CHLORIDE — Original Application (PAI Holdings, LLC dba PAI Pharma)

View source ↗

Summary

FDA approves the original application for Potassium Chloride (generic electrolyte supplement) from PAI Holdings dba PAI Pharma under ANDA210766.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Potassium chloride (Potassium chloride)

Snippet

ORIG AP for POTASSIUM CHLORIDE (POTASSIUM CHLORIDE)